Cancer-associated SHP-2 (SH2 Domain-Containing Protein Tyrosine Phosphatase 2) mutants recruit the wild-type SHP2 protein into phase-separated condensates that promote the activation of oncogenic RAS-MAP kinase signaling (Figure 1A) [34]. Here, PTPN11 is linked to cancer.